These findings suggest that BBV152 was associated with protection against both symptomatic and asymptomatic reinfection in HCWs after a complete vaccination schedule, when the predominant circulating variant was B.1.617.2.
No takes yet. Share an insight, caveat, or question.
Malhotra et al. (2022) studied this question.